Quest Diagnostics Incorporated (DGX) vs Natera, Inc. (NTRA)
- Quest Diagnostics Incorporated DGX 235.00 −1.74%
- Natera, Inc. NTRA 391.98 −3.16%
Quest Diagnostics Incorporated and Natera, Inc. are both Diagnostics & Research companies. Natera, Inc. is the larger, with a market value of $58.4B against $26.4B — 2.2× the size. Natera, Inc. has negative trailing earnings, so its P/E is not meaningful; Quest Diagnostics Incorporated trades at 24.6×. Natera, Inc. grew revenue faster over the last twelve months: 37.8% against 9.87%. Quest Diagnostics Incorporated has the higher net margin (9.15% vs −7.11%) and the higher return on invested capital (7.94% vs −22.3%). Across the 20 metrics below, Quest Diagnostics Incorporated leads on 14 and Natera, Inc. on 6.
Valuation
Profitability
| Metric | DGX | NTRA | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 33.11% | 65.23% | 50.89% |
| Operating margin | 14.10% | (10.70%) | (8.57%) |
| Net margin | 9.15% | (7.11%) | (6.37%) |
| Free cash flow margin | 11.67% | 3.11% | 0.00% |
| Return on equity | 14.03% | (12.54%) | (2.92%) |
| Return on assets | 6.43% | (8.71%) | (6.71%) |
| Return on invested capital | 7.94% | (22.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack